McKesson | MCK - Ebitda

Aktienkurs
944.36
Täglich Wechseln
10.07 1.08%
Monatlich
1.03%
Jährlich
46.71%
Q1 Prognose
891.50




Ebitda Veränderung Datum
Acadia Healthcare USD 99.85M 73.17M 2025-12
Align Technology USD 183.84M 19.77M 2025-09
Cardinal Health USD 981M 5M 2025-12
Centene USD -903M 1.02B 2025-12
Charles River Laboratories USD 258.06M 24.83M 2025-12
Cigna USD 2.86B 56M 2025-03
Community Health Systems USD 425M 33M 2024-12
CVS Health USD 3.74B 349M 2025-12
DaVita Healthcare Partners USD 772.7M 89.45M 2025-12
Dentsply International USD 135M 32M 2025-12
Elevance Health USD 2.19B 1.01B 2025-09
Encompass Health USD 335.6M 35.5M 2025-12
HCA USD 4.11B 244M 2025-12
Henry Schein USD 291M 4M 2025-12
Humana USD -290M 1.11B 2025-12
IQVIA Holdings USD 1.05B 97M 2025-12
J&J USD 9.52B 389M 2025-09
Laboratory Of America USD 588.1M 24.1M 2025-12
McKesson USD 1.68B 418M 2025-09
Molina Healthcare USD 185M 265M 2025-09
Owens Minor USD 96.6M 12.17M 2025-06
Quest Diagnostics USD 537M 24M 2025-12
Stryker USD 1.67B 206M 2025-09
Tenet Healthcare USD 1.18B 84M 2025-12
UnitedHealth USD 1.5B 3.92B 2025-12
Universal Health Services USD 678.67M 8.07M 2025-12
Veradigm USD 38.81M 29.61M 2022-09